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Impact of dialyzer membrane selection on cellular responses to either attenuate the severity of the renal failure or
in acute renal failure: A crossover study. hasten recovery, and technological advances in dialysis
Background. When acute renal failure (ARF) is severe delivery, the outcome of ARF has remained poor, withenough to require dialysis, in-hospital mortality rates approach
mortality rates exceeding 50% [1]. This high mortality60%. These alarming figures have been ascribed in part to
is not explained entirely by advanced age and underlyingadvanced age and the high prevalence of comorbid conditions.
In the past several years, a number of attempts have been comorbid conditions. In fact, recent data indicate that
made to investigate the impact of dialyzer membrane type ARF per se increases the risk of developing severe non-
on clinical outcomes. Unfortunately, to date, clinical studies renal complications that lead to death [2].addressing this question have reported conflicting results.
Nevertheless, when patients with ARF require dialyticMethods. This crossover study examined the effect of dia-
lyzer membrane type on cytokine synthesis by peripheral blood support, there are several considerations regarding the
mononuclear cells (PBMCs), superoxide release by neutrophils, use of renal replacement therapy. These include the tim-
and apoptosis or programmed cell death of neutrophils in 24 ing of initiation, the modality, the type of dialyzer mem-patients with ARF requiring intermittent hemodialysis. The pa-
brane, and the dose of dialysis. Although most of thesetients were assigned in an alternate order to a low-flux cellulose
questions have not been adequately addressed, the typeacetate (CA) or polysulfone (PS) dialyzer. After three consecu-
tive dialysis sessions, patients were crossed over to the second of dialyzer membrane used during intermittent hemodi-
dialyzer for three additional treatments. These cellular responses alysis (IHD) has received the most attention. Indeed,
were measured upon dialyzer assignment and at the third and the impact of biocompatibility of dialyzer membranessixth dialysis session in relationship to the dialyzer type.
on clinical outcomes in patients with ARF requiring IHDResults. The results of the study showed no impact of dia-
lyzer biocompatibility on synthesis of tumor necrosis factor-a remains a subject of ongoing debate. Although some
(TNF-a) or interleukin 10 (IL-10) by PBMCs, superoxide re- clinical trials have suggested an association between the
lease by neutrophils, or neutrophil apoptosis. This held true use of biocompatible dialyzer membranes and clinicalregardless of the initial dialyzer assignment. Furthermore,
outcomes in ARF [3–6], other more recent studies havethere was no correlation between dialysis adequacy (measured
not confirmed these findings (abstracts; Gastaldello etby single-pool Kt/V) and postdialysis cellular responses.
Conclusions. In summary, this study refines the question of al, J Am Soc Nephrol 7:1447, 1996; Albright et al, J Am
biocompatibility by comparing a substituted cellulose rather Soc Nephrol 9:197A, 1998; Jo¨rres et al, J Am Soc Nephrol
than unsubstituted cellulose dialyzer to a PS dialyzer in the 9:212A, 1998) [7]. More importantly, even among studiessetting of ARF. The results failed to demonstrate a dialyzer
that did demonstrate an association between the dialyzeradvantage on the selected cellular responses.
membrane type and clinical outcomes, the biological ba-
sis behind the benefit was not examined.
Numerous studies performed in patients with chronicDespite considerable advances in the treatment of hos-
pital-acquired acute renal failure (ARF), including bet- renal failure have demonstrated that blood–dialyzer
ter supportive care, novel pharmacological manipulation membrane interactions, particularly during dialysis with
unsubstituted cellulose membranes, result in comple-
ment and leukocyte activation [8]. These interactionsKey words: membrane biocompatibility, acute renal failure, dialysis,
cytokines, superoxide, apoptosis. lead to the generation and release of cytokines by periph-
eral blood mononuclear cells (PBMCs) [9, 10] and theReceived for publication July 12, 1999
production of reactive oxygen species by neutrophilsand in revised form October 22, 1999
Accepted for publication November 25, 1999 [11]. However, in ARF, few data are available on the
activation of cellular and plasma elements by differentÓ 2000 by the International Society of Nephrology
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dialyzer membranes during IHD [3, 12]. Unlike end- indices and the type of dialyzer membrane, nutritional
indices, and adequacy of dialysis was analyzed.stage renal disease (ESRD) patients on chronic hemodi-
alysis, patients with ARF who require IHD are often
Blood sample collectioncritically ill, infected, and have activation of several in-
Heparinized whole blood (10 IU/mL) was drawn fromflammatory and counter-regulatory pathways. Conse-
the arterial port of the dialysis catheter immediately be-quently, the biological responses to membrane biocom-
fore dialysis and at the end of dialysis when indicated. Inpatibility among patients with ARF are likely to be
all instances and at each time point, a 12 mL heparinizeddifferent from those among ESRD patients.
whole blood sample was obtained from each patient; 10The purpose of this study was to elucidate the impact
mL were used to harvest neutrophils, and plasma andof dialyzer membrane selection on indices of biocompati-
serum were separated from the remaining 2 mL. Allbility in patients with ARF requiring IHD. Specifically,
plasma and serum samples were stored at 2708C.the objectives were to evaluate the effect of dialyzer
membrane selection on proinflammatory and anti-in-
Clinical data collectionflammatory cytokine production by mononuclear cells,
During the course of the study, the baseline demo-superoxide (O2x2) release by neutrophils, and cellular
graphic and clinical follow-up data were abstracted fromapoptosis.
the patients’ hospital records. These included age, gen-
der, cause of ARF, presence or absence of the systemic
METHODS inflammatory response syndrome (SIRS) [13], and urine
output 24 hours before the initiation of dialysis. TheStudy design
severity of illness in each patient was determined usingAll patients over 18 years of age who were hospitalized
the Acute Physiological and Chronic Health Evaluationat the New England Medical Center and required initia-
or APACHE II score [14] prior to the first dialysis. Thistion of IHD for ARF were eligible for enrollment in the
score has been widely used in critically ill patients andstudy. The study was approved by the Human Investiga-
represents the sum of risks added by computing variablestion Review Committee. Informed consent was obtained
that include age, current physiological variables, and pre-from patients, whenever possible, or from their next of
existing chronic diseases. The number of organ systemkin. Pregnant female patients were excluded from the
failures was also determined using the Multiple Organ
study, as well as patients who were known to have human
Failure (MOF) score.
immunodeficiency virus (HIV) infection, had undergone
Several other factors that can have a great influence on
renal, liver, heart, or bone marrow transplantation, had the assessment of immune functions in ARF, including
documented chronic renal insufficiency (baseline serum nutritional indices (serum albumin, urea generation or
creatinine . 2 mg/dL), or required isolated ultrafiltration protein catabolic rate, caloric, and protein intake), mea-
for fluid overload. All decisions regarding the initiation sures of dialysis adequacy (urea reduction ratio and sin-
or discontinuation of dialysis were made by the treating gle-pool Kt/V), and the microbiological quality of the
nephrologist, without consultation with the investigators dialysate, were recorded throughout the study period.
or knowledge of the dialyzer in use.
Once a decision had been made to initiate hemodialy- PBMC isolation
sis, the patients were assigned to a low-flux substituted Water, cell culture media, and other solutions used
cellulose (CAHP170t, 1.7 m2; Baxter HealthCare Corpo- in the study were subjected to ultrafiltration using a poly-
ration, McGaw Park, IL, USA) or a low-flux polysulfone amide hollow-fiber ultrafilter (U2000; Gambro AB, Hech-
(PS; F8t, 8 m2; Fresenius USA, Walnut Creek, CA, USA) ingen, Germany) to remove cytokine-inducing agents.
dialyzer membrane, in an alternate order, for three dial- PBMCs were harvested by Ficoll-Hypaque separation [15].
ysis sessions (Fig. 1). A sample of blood was drawn prior In brief, each 10 mL sample of heparinized (10 IU/mL)
to the first dialysis session. At the third dialysis treat- blood was diluted in 20 mL of normal saline (Abbott
ment, a sample of blood was collected immediately be- Laboratories, Rockford, IL, USA), underlayered with
fore the start and at the end of dialysis. For the fourth 10 mL of Ficoll-Hypaque (Sigma Chemical Co., St.
dialysis treatment, patients were crossed over to the sec- Louis, MO, USA; Nycomed Inc., New York, NY, USA),
ond dialyzer for the following three sessions. At the third and centrifuged at 450 3 g for 40 minutes at room tem-
dialysis treatment with the new dialyzer (that is, at the perature. The PBMC layer was harvested, washed in
overall sixth dialysis session), a sample of blood was normal saline, and centrifuged at 400 3 g for 10 minutes.
collected before the start and at the end of dialysis. PBMCs were washed in saline two additional times, sus-
At each time point, cytokine production by PBMCs, pended in saline, and counted using a standard hemocy-
superoxide release by neutrophils, and cellular apoptosis tometer. The purity of PBMCs was greater than 90%,
and viability was greater than 95%, as judged by thewere determined, and the relationship between these
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lysis. This procedure was repeated once or twice until
the cell pellet appeared relatively free of erythrocytes.
Cells were suspended in ice-cold PBS, and neutrophils
were counted using a standard hemocytometer. The pu-
rity of neutrophils was greater than 95%, and the viability
was greater than 99%, as judged by the trypan blue
exclusion method. Neutrophils were resuspended at 5 3
106 cells/mL in Hank’s balanced salt solution (HBSS) for
functional assays or in RPMI-1640 supplemented with
l-glutamine, NaHCO3, HEPES, penicillin, and strepto-
mycin, for culture conditions.
In vitro synthesis of TNF-a and IL-10 by PBMCs
A 0.5 mL suspension of PBMCs was aliquoted into
a 12 3 75 mm polypropylene tube (Becton Dickinson
Labware, Lincoln Park, NJ, USA), and 0.5 mL of RPMI-
1640 with or without 20 ng/mL of purified Escherichia
coli endotoxin (serotype 055:B5, Sigma Chemical Co.)
was added. All tubes were then incubated upright in a
humidified atmosphere at 378C with 5% CO2. At the end
of 24 hours, the cell suspensions were subjected to three
freeze-thaw (2708C) cycles for measurement of total
cytokine synthesis (cell associated and secreted).
Tumor necrosis factor-a and IL-10 synthesis were
measured by a sandwich enzyme-linked immunosorbent
assay (ELISA), according to the manufacturer’s instruc-
tions (Quantikinee; R&D Systems, Minneapolis, MN,
USA). Undiluted and diluted samples were assayed in
the manufacturer’s calibrator diluent. Lower limits of
detection for TNF-a and IL-10 were 4.4 and 2 pg/mL,
respectively. The average intra-assay coefficient of varia-
tion for TNF-a and IL-10 was #5.3% and #6.6%, respec-
tively. The average interassay coefficient of variation for
TNF-a and IL-10 was #8.7% and #7.6%, respectively.
However, in order to eliminate interassay variability, all
samples from each patient were tested in a single assay.
Fig. 1. Trial profile.
Superoxide release by neutrophils
The release of O2x2 by neutrophils was determined by
measuring the capacity of cells to reduce ferricytochrometrypan blue exclusion method. PBMCs were finally resus-
pended at 2 3 106 cells/mL in ultrafiltered culture me- to ferrocytochrome C [15]. In brief, upon isolation, neu-
trophil aliquots of 125 mL (6.25 3 105 cells) were incu-dium containing RPMI-1640 (pH 7.4; Sigma Chemical
Co.), 10 mmol/L l-glutamine, 24 mmol/L NaHCO3 (Mal- bated in Eppendorfe tubes (USA/Scientific Plastic,
Ocala, FL, USA) in the presence of 25 mL of ferricyto-linckrodt, Paris, KY, USA), 10 mmol/L HEPES (Sigma
Chemical Co.), 100 U/mL penicillin, and 100 mg/mL chrome C (12.3 mg/mL; Sigma Chemical Co.), 25 mL of
stimuli [10 nmol/L solution of 4-b phorbol 12-b-myristatestreptomycin (Irvine Scientific, Santa Ana, CA, USA).
13-a-acetate (PMA; Sigma Chemical Co.) or 10 mmol/L
Neutrophil isolation solution of N-formyl methionyl-leucyl-phenylalanine
(fMLP; Sigma Chemical Co.)] with or without 25 mL ofAfter harvesting the mononuclear cell layer, Dulbec-
co’s phosphate-buffered saline (PBS) (GIBCO BRL Life superoxide dismutase (SOD, 1 mg/mL; Sigma Chemical
Co.). HBSS was added to finalize the volume at 250 mL.Technologies, Grand Island, NY, USA) and 3% dextran
(Sigma Chemical Co.) were added to the buffy coat. After a 10-minute incubation at 378C with rotational
agitation, the tubes were placed on ice and centrifuged atAfter 15 minutes, the leukocyte-rich supernatant was
harvested and centrifuged at 450 3 g for five minutes at 14,000 r.p.m. for one minute at 48C. Control experiments
were run in parallel using 25 mL of HBSS instead of48C. Residual erythrocytes were subjected to hypotonic
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stimuli. All experiments were performed in duplicate. The proportion of apoptotic neutrophils was defined as
The amount of O2x2 produced was quantitated by mea- the number of apoptotic cells divided by the total number
suring the change in spectrophotometric absorbance of of cells 3 100.
the cell-free supernatant at dual wavelength (550 nm test
filter with a reference wave length of 570 nm), using a Measurement of urea kinetic modeling
microplate reader (MRX-500; Dynatech Laboratories The delivered dose of dialysis was assessed by “single-
Inc., Chantilly, VA, USA). The results are expressed as pool” urea kinetic modeling, using the Daugirdas for-
nanomoles of O2x2 produced/6.25 3 105 cells/10 min, mula [17]:
based on an extinction coefficient for a 1 cm light path
(ferro–ferri) of 21.1. spKt/V 5 ln (R 2 0.008 * t) 1 (4 2 3.5R) * UF/W
Culture conditions for neutrophils where R is post/predialysis blood urea nitrogen (BUN),
t is the dialysis time (hours), UF is the ultrafiltration rateNeutrophils (2.5 3 106) were aliquoted into 12 3 75
(L), and W is the weight (kg).mm polystyrene tubes (Becton Dickinson Labware) and
In brief, immediately before dialysis, a predialysiscentrifuged at 450 3 g for five minutes at 48C. The cells
were resuspended in 1 mL of ultrafiltered culture me- blood sample was drawn from the arterial port of the
dium supplemented with 10% fetal calf serum (FCS) catheter for measurement of BUN. At the end of the
and then incubated for 24 hours upright in a humidified dialysis session, blood flow (Qb) was reduced to 80 mL/
atmosphere at 378C with 5% CO2. After the incubation min for 20 seconds. The blood pump was turned off, and
period, neutrophils were gently resuspended in the same a postdialysis blood sample was drawn from the arterial
medium, washed with 3 mL of PBS, and centrifuged at port of the catheter for measuring BUN.
450 3 g for five minutes at 48C. The cell pellets were then
fixed in 2 mL of chilled 70% ethanol (Aaper Alcohol & Statistical analysis
Chemical Co., Shelbyville, KY, USA) and incubated at
Baseline demographic data were compared between48C for a minimum of one hour. Neutrophils were then
the patients who were first assigned to the CA dialyzerprocessed for quantitation of apoptosis.
and the patients first assigned to the PS dialyzer. The chi-
square test was used to compare the gender distributionMeasurement of apoptosis
between the two groups, and Student’s t-test to compareNeutrophil apoptosis was measured by flow cytometry
all other measurements, including mean age, APACHEaccording to a modified version of a previously described
score, number of organ failures, and laboratory values.technique [16]. This method of detecting apoptosis is
Baseline cellular responses between the two groups werebased on the cellular loss of low molecular weight DNA
also compared using the Student’s t-test. Because thefragments that leak out of apoptotic cells. As a result of
the activation of an endonuclease that cleaves DNA, distributions of the cytokine data were skewed, the natu-
apoptotic cells have a low DNA content, therefore less ral log of these data was used in the analyses. Data are
DNA stainability. In brief, ethanol-fixed neutrophils presented in tables as either percentages or means 6 SD.
were centrifuged at 450 3 g for five minutes, resupsended Postdialysis cytokine synthesis by PBMCs, superoxide
in PBS, and stained with 50 mg/mL of propidium iodide release by neutrophils, and apoptosis of neutrophils dur-
(PI; Sigma Chemical Co.). The cells were incubated in ing IHD were compared between dialyzers using the
the dark at room temperature for 15 minutes and then method of least squares to perform a repeated measures-
immediately subjected to flow cytometric analysis. Flow analysis of variance (ANOVA) where the predialysis
cytometric analysis was carried out at a flow rate of value was included as a covariate. These analyses were
1000 events per second using a dual laser flow cytometer stratified by the first dialyzer allocation, where “group
(EPICSt XL-MCL; Coulter Corporation, Miami, FL,
1” refers to patients who were first assigned to the CA
USA). A total of 10,000 events was counted. Cell debris
dialyzer (N 5 11), and “group 2” refers to patients whoand clumps were excluded from the analysis by gating
were assigned the PS dialyzer (N 5 13). Relationshipssingle cells in the forward and side light scatters. PI was
between dialysis dose and cytokine synthesis, superoxideexcited using the 488 nm ultraviolet line of the Argon
release, and apoptosis were examined by calculating uni-laser. For each donor, neutrophils were immediately
variate R2 and partial R2 (adjusted for predialysis values,fixed after isolation and analyzed first in order to deter-
dialyzer type, and study period), and corresponding Pmine the gates delineating the sub-G0/1 hypodiploid cell
values were examined using least-squares linear regres-population with low PI uptake. Neutrophils with low PI
sion analysis. All analyses were performed using the SASuptake were considered apoptotic. Acquired data were
system for Windows, version 6.12. Findings with P valuesanalyzed by a PC-based software (WinMDI version 2.6;
The Scripps Research Institute, La Jolla, CA, USA). #0.05 were considered statistically significant.
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Table 2. Baseline cellular responsesTable 1. Baseline demographic, clinical and laboratory data
Cellulose Cellulose
acetate Polysulfoneacetate Polysulfone
(N 5 11) (N 5 13) P value (N 5 11) (N 5 13) P value
Log TNF-a productionGender % male 45 69 0.24
Age years 71611 61616 0.08 pg/10 6 PBMC
Unstimulated 2.562.5 2.361.1 0.82APACHE II score 2767 24 68 0.35
Number of organ failure 261 261 0.71 LPS-stimulated 6.161.3 5.661.5 0.45
Log IL-10 productionSIRS % 82 54 0.15
Serum albumin g/dL 2.260.5 2.360.7 0.51 pg/10 6 PBMC
Unstimulated 1.060.8 0.960.7 0.63BUN mg/dL 103642 91633 0.44
Serum creatinine mg/dL LPS-stimulated 3.561.6 2.661.7 0.20
Log TNF-a:IL-10 ratioat admission 1.460.4 1.460.5 0.92
at renal consult 3.561.9 4.160.4 0.63 Unstimulated 1.561.9 1.461.5 0.94
LPS-stimulated 2.561.5 3.061.9 0.51at initiation of dialysis 4.261.4 4.861.7 0.39
Urine output 24 hours prior O2x2 release
nmol/6.25 3 10 5 PMN/10 minto dialysis mL/24 h 9456945 93461310 0.99
Unstimulated 0.660.7 1.762.8 0.22SIRS is systemic inflammatory response syndrome.
fMLP-stimulated 6.167.5 4.563.5 0.63
PMA-stimulated 32.6613.0 34.0614.4 0.82
Neutrophil apoptosis % 20618 765 0.08
RESULTS
Baseline characteristics
recommended guidelines of the Association for the Ad-The study was initiated on July 1, 1996, and patients’
vancement of Medical Instrumentation (#2000 CFU/mL).enrollment ended on February 11, 1998. A total of 181
consecutive patients with ARF were initiated on IHD Cytokine synthesis by PBMCs during IHD with CA
during the study period. One hundred twenty-nine pa- versus PS dialyzer membranes
tients were excluded for the following reasons: pre-exist-
As shown in Figure 2, after adjustment for the predial-
ing chronic renal insufficiency (N 5 68); kidney (9), liver
ysis values, postdialysis TNF-a synthesis by unstimulated
(15), heart (5) and bone marrow transplantation (7);
and lipopolysaccharide (LPS)-stimulated PBMC was not
HIV infection (3); pregnancy (2); active immunologic significantly different between the dialysis sessions per-
disease (9); active malignancy (6); obstructive uropathy formed with CA versus PS dialyzer membranes regard-
with reversible cause (4); and isolated ultrafitration (1). less of initial dialyzer membrane assignment (P 5 0.52
Of the remaining 52 patients, 23 potential candidates and P 5 0.40, respectively, for group 1, Fig. 2A; P 5
required IHD emergently prior to notification of the NA and P 5 0.29, respectively, for group 2, Fig. 2B).
investigators, four patients declined enrollment, and one Similarly, after adjustment for the predialysis values,
patient withdrew from the study immediately after ran- postdialysis IL-10 synthesis by unstimulated and LPS-
domization. stimulated PBMCs was not significantly different be-
Twenty-four patients with ARF were ultimately en- tween the dialysis sessions performed with CA versus
rolled in the study. Their baseline demographic and clini- PS dialyzer membranes (P 5 0.65 and P 5 0.39, respec-
cal characteristics are shown in Table 1. There were no tively, for group 1, Fig. 2C; P 5 0.34 and P 5 0.88,
statistically significant differences regarding age, gender, respectively, for group 2, Fig. 2D). This held true regard-
etiology of ARF, baseline serum creatinine, degree of less of initial dialyzer membrane assignment.
azotemia at the start of dialysis, APACHE II score, num-
Superoxide release by neutrophils during IHD withber of organ failure, and presence of SIRS between the
CA versus PS dialyzer membranestwo groups. The baseline measured immunologic param-
eters are shown in Table 2. There were no statistically Likewise, as shown in Figure 3, after adjustment for
significant differences regarding TNF-a and IL-10 syn- the predialysis values, postdialysis O2x2 release by un-
thesis by PBMCs, unstimulated and PMA-stimulated su- stimulated and PMA-stimulated neutrophils was not sig-
peroxide release by neutrophils, and apoptosis of neutro- nificantly different between the dialysis sessions per-
phils between the two groups. formed with CA versus PS dialyzer membranes (P 5
There were no statistically significant differences in 0.70 and P 5 0.45, respectively, for group 1, Fig. 3A;
the baseline measured cellular responses between pa- P 5 0.42 and P 5 0.73, respectively, for group 2, Fig. 3B).
tients with and without sepsis (or SIRS; data not shown). However, after adjustment for the predialysis values,
The bacterial count of the dialysate water was moni- postdialysis O2x2 release by fMLP-stimulated neutrophils
tored throughout the study period. The mean count was was somewhat different between the dialysis sessions
performed with CA versus PS dialyzer membranes (P 520 6 42 colony-forming unit (CFU)/mL, which met the
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Fig. 2. Cytokine synthesis by peripheral blood mononuclear cells (PBMCs) during intermittent hemodialysis (IHD). Unstimulated ( ) and
endotoxin-stimulated (j) tumor necrosis factor-a (TNF-a; A and B) and interleukin-10 (IL-10; C and D) synthesis by PBMCs were not significantly
different between the dialysis sessions performed with cellulose acetate (CA) versus polysulfone (PS) dialyzer membranes, regardless of initial
dialyzer membrane assignment. The dotted lines represent the mean values of unstimulated (gray dotted line) and endotoxin-stimulated (black
dotted line) cytokine synthesis by PBMCs harvested from five healthy volunteers. Unstimulated and endotoxin-stimulated TNF-a production was
6.0 [95% confidence interval (CI), 2.5 to 9.4] and 7.8 pg/106 PBMC (95% CI, 7.3 to 8.2), respectively (A and B).
0.51 and P 5 0.04, respectively, for groups 1 and 2; Fig. Correlation between dialysis dose and cytokine
synthesis, superoxide release, and apoptosis3A and 3B).
The mean delivered dose of dialysis for all dialytic
Apoptosis of neutrophils during IHD with CA versus
sessions during the study period, as measured by spKt/V,
PS dialyzer membranes
was 0.91 6 0.21. As shown in Table 3, using linear regres-
In group 1, after adjustment for the predialysis values, sion models, no relationship was observed between dial-
the proportion of neutrophils undergoing apoptosis was ysis dose (spKt/V) and postdialysis cytokine synthesis,
significantly higher following dialysis sessions performed superoxide release by neutrophils, and apoptosis.
with CA versus PS dialyzer membranes (P 5 0.03; Fig.
4). However, in group 2, where the dialyzer membrane
DISCUSSIONassignment was reversed, there were no significant differ-
ences in neutrophil apoptotic rates between the two dia- The high morbidity and mortality among patients with
ARF are commonly attributed to the underlying dis-lyzer membranes (P 5 0.36; Fig. 4).
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Fig. 3. Superoxide release by neutrophils during IHD. Unstimulated ( ) and PMA-stimulated release (j) of O2x2 by neutrophils was not
significantly different between the dialysis sessions performed with cellulose acetate (CA) versus polysulfone (PS) dialyzer membranes, regardless
of initial dialyzer membrane assignment (A and B). However, in group 2 (B), fMLP-stimulated release (h) of O2x2 by neutrophils was significantly
higher following dialysis with CA rather than PS dialyzers (P 5 0.04). The dotted lines represent mean values of unstimulated (gray dotted line),
fMLP- (black dotted line), and PMA-stimulated (black line) release of O2x2 by neutrophils harvested from healthy volunteers.
pathways. Indeed, in patients with ARF, IHD with un-
substituted cellulose dialyzer membranes has been
shown to induce intense and transient activation of the
complement system (C3a) [3] and lipooxygenase path-
way (leukotriene B4) [3]. Cellular activation in ARF,
however, has received little attention. In fact, only one
study performed in patients with ARF demonstrated
increased release of elastase by degranulating neutro-
phils during IHD with unsubstituted cellulose mem-
branes [12].
The purpose of this study was to elucidate the impact
of dialyzer membrane selection on cellular responses inFig. 4. Apoptosis of neutrophils during IHD. In group 1 (patients initi-
ated on a CA dialyzer), the proportion of neutrophils undergoing apo- patients with ARF requiring IHD. The effects of dialyzer
ptosis (data presented as adjusted mean values) was significantly higher membrane selection on proinflammatory and anti-inflam-following dialysis with a CA (h) versus PS (j) dialyzer (*P 5 0.03).
matory cytokine production by mononuclear cells, O2x2The mean apoptosis of neutrophils harvested from healthy volunteers
was 19% (95% confidence interval, 1.0 to 37.4). release by neutrophils, and cellular apoptosis were ex-
amined. We attempted to eliminate as many potential
sources of bias as possible. Studies performed in patients
with chronic renal failure (CRF) suggest that the inter-ease(s) and the high frequency of superimposed compli-
pretation of cytokine levels must take into account thecations, mainly infections, rather than complications re-
type and duration of exposure to a particular dialyzerlated to the renal failure per se [1]. In addition, it has
membrane before their measurement [18, 19]. Therefore,been suggested that the type of dialyzer membrane used
the design of this study took these considerations intoin patients with ARF may have an impact on clinical
account, and each patient was dialyzed for three consecu-outcomes, such as bacterial sepsis [5], recovery of renal
tive times with each dialyzer membrane prior to measur-function, and death [3, 4, 6]. However, several studies
ing cytokine synthesis by mononuclear cells. In addition,have not validated these concerns (abstracts; Gastaldello
to eliminate the influence of flux and dose of dialysis,et al, J Am Soc Nephrol 7:1447, 1996; Albright et al, J
we used two low-flux dialyzers that had similar smallAm Soc Nephrol 9:197A, 1998; Jo¨rres et al, J Am Soc
solute clearance characteristics.Nephrol 9:212A, 1998) [7]. Moreover, few published data
Cellular responses of patients with ARF who receiveare available on the actual measurement of the various
IHD have not been adequately investigated. Patientsbiocompatibility indices in patients with ARF who re-
with ARF are frequently critically ill, and their clinicalquire IHD. While exposure to various dialyzer mem-
course is often confounded by the presence of the SIRSbranes can result in perturbations of both plasma and
caused by sepsis. Indeed, sepsis precedes ARF in aboutcellular components of the blood, clinical reports have
thus far been limited to activation of various humoral 50% of cases [20, 21]. The cytokine network in sepsis
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Table 3. Correlation between dialysis dose (spKt/V) and post-dialysis cytokine synthesis, superoxide release and apoptosis
LPS-stimulated PMA-stimulated fMLP-stimulated
Neutrophil
spKt/V model variables TNFa synthesis IL-10 synthesis apoptosissuperoxide release
Unadjusted 0.04:0.40 0.00:0.86 0.00:0.99 0.00:0.93 0.16:0.06
Adjusted for predialysis values 0.06:0.27 0.00:0.76 0.00:0.99 0.00:0.49 0.00:0.91
Adjusted for predialysis values,
Dialyzer type and crossover period 0.04:0.42 0.00:0.99 0.00:0.99 0.00:0.87 0.01:0.63
Data are partial r2: P value.
is characterized by a proinflammatory state that is a duces superoxide radical when the cell is activated, as
a component of the bacterial armamentarium [30]. Inconsequence of an efficient but exaggerated host defense
system [22]. TNF-a “proinflammatory cytokine” plays a patients with chronic renal failure, dialysis with cupro-
phane (CU) membranes results in increased spontaneouspivotal role in the pathogenesis of sepsis. In recent years,
however, the compensatory anti-inflammatory response hydrogen peroxide production by neutrophils, along with
decreased neutrophil responsiveness to Staphylococcussyndrome (CARS) has emerged as a new concept [23–25].
This anti-inflammatory state is distinguished by an in- aureus challenge [31]. These findings document the po-
tential role of oxidative stress in hemodialysis-associatedcreased production of “anti-inflammatory cytokines,”
such as IL-4, IL-10, and transforming growth factor-b morbidity and susceptibility to infection. In this study,
however, the ability of neutrophils to generate superox-(TGF-b). In healthy subjects, IL-10, a regulator of mono-
cyte activation, down-regulates the production of proin- ide in response to PMA, a cell-receptor–independent
stimulus, was not affected by dialysis with either CA orflammatory cytokines [26]. Studies in chronically hemo-
dialyzed patients suggest that increased IL-10 production PS dialyzer membranes. However, fMLP, a cell-recep-
tor–dependent stimulus, was somewhat affected by thein vitro correlates with clinical immunocompetence [27].
In addition, recent studies have shown that in healthy order of dialyzer assignment. Indeed, in group 2, postdi-
alysis fMLP-stimulated superoxide values were some-subjects, subpopulations of monocytes produce exclu-
sively IL-10, whereas in dialysis patients, this cytokine- what higher in patients dialyzed with CA rather than PS
dialyzer. Since it was not reproducible in group 1, thespecific cell differentiation is lost [28]. Consequently, in
this study, we selected TNF-a and IL-10 production by significance of this finding is unclear.
Dialysis factors can result in the activation of circulat-mononuclear cells, as markers of both the proinflamma-
tory and anti-inflammatory cascades. The results of the ing neutrophils, causing up-regulation of cell-surface ad-
hesion molecules [32]. In the setting of microvascularstudy suggest that in patients with ARF who require
IHD, the use of a substituted cellulose dialyzer mem- endothelial injury, this may result in the migration of
activated neutrophils from the vasculature into inflam-brane does not attenuate the ability of PBMCs to synthe-
size cytokines. This is reflected by the relatively unchanged matory sites [29, 33] and release of reactive oxygen spe-
cies and proteolytic enzymes. Consequently, bystanderTNF-a and IL-10 synthesis by PBMCs when challenged
with endotoxin before and after dialysis. The use of tissue injury is a consequence of local neutrophil activa-
tion. The termination of a neutrophil-mediated inflam-PS—a more biocompatible dialyzer membrane—in the
same patient population had similar effects. matory response is effected through the programmed cell
death or apoptosis of the neutrophil. Normal neutrophilsSuperoxide is a free radical that is derived from molec-
ular oxygen by the addition of a single electron. Reactions survive for less than a day in the circulation before dying
through this process of regulated cell death. In patientsthat produce superoxide biologically occur under a broad
spectrum of physiological and pathological circumstances, with CRF, programmed cell death of neutrophils is in-
creased [34] and can be modulated by environmentalincluding all infectious and inflammatory diseases, as well
as in disease processes that involve ischemia and reperfu- signals, including dialysis-related (abstract; Himmelfarb
and McMenamin, J Am Soc Nephrol 8:237A, 1997) assion, such as in ischemic acute tubular necrosis [29]. Super-
oxide metabolites, particularly hydroxyl radicals, result well as uremic factors [35]. In patients with sepsis, how-
ever, apoptosis of neutrophils is delayed [36]. In ourin lipid peroxidation of cell-membrane fatty acids, as well
as lipoproteins, proteins, and nucleic acids. Although the study, the proportion of apoptotic neutrophils in all 24
patients prior to the initiation of dialysis was significantlyconsequences are often subtle, such damage may alter
cellular regulatory mechanisms such as signal transduc- lower than that seen in patients with CRF (14 6 4 vs.
31 6 6%) [34]. Furthermore, neutrophil apoptosis wastion and possibly cell survival.
Neutrophils possess a reduced nicotinamide adenine not influenced by dialysis regardless of the dialyzer type,
with the exception of patients who were first assigneddinucleotide phosphate (NAPDH) oxidase that pro-
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grateful for Dr. William R. Clark who reviewed this manuscript. Thisto CA and then crossed over to PS. In this patient group
work was presented in part at the 30th Annual Meeting of the American
(group 1), apoptotic rates were significantly lower follow- Society of Nephrology, San Antonio, TX, USA, November 2–5, 1997.
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pating in this study. Finally, we thank the nursing staff of the in-patientfinding is unclear.
hemodialysis unit of New England Medical Center for their help in
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